Company Filing History:
Years Active: 2011
Title: The Innovations of Stefan Pflanz
Introduction
Stefan Pflanz is a notable inventor based in Redwood City, CA. He is recognized for his contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work has significant implications for medical treatments and research.
Latest Patents
Stefan Pflanz holds a patent for Anti-IL2 antibodies. This invention relates to a humanized monoclonal antibody or fragment that specifically binds to human interleukin-2 (IL2). The humanized monoclonal antibody neutralizes the activity of human IL2 by binding to it prior to, during, and/or subsequent to its binding to the human IL2-receptor. Notably, the light chain variable region of this antibody comprises the contiguous amino acid sequence KAPKA at amino acid positions 42-46. This innovation showcases his expertise in antibody engineering and therapeutic development.
Career Highlights
Stefan Pflanz has made significant strides in his career, particularly through his work at Micromet AG. His research and inventions have contributed to advancements in immunotherapy and have the potential to improve treatment options for various diseases.
Collaborations
Stefan has collaborated with esteemed colleagues such as Patrick Bäuerle and John Lumsden. These partnerships have fostered innovation and have been instrumental in the development of groundbreaking therapies.
Conclusion
Stefan Pflanz's contributions to the field of biotechnology, particularly through his patent for Anti-IL2 antibodies, highlight his role as a leading inventor. His work continues to influence the landscape of medical research and therapeutic development.